Hytrin (Terazosin Hydrochloride Dihydrate)

Terazosin selectively blocks alpha‑1 adrenergic receptors on vascular and prostatic smooth muscle. This inhibition prevents norepinephrine‑induced contraction, leading to vasodilation that reduces peripheral resistance and to relaxation of prostatic tissue, which eases urinary obstruction.

The exact dosage of Hytrin is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Physicians typically start with a low dose and may adjust gradually to achieve the desired blood‑pressure control or symptom relief.

Hytrin is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are no adequate human studies. It should only be used during pregnancy if clearly needed. Terazosin is excreted in breast milk, so nursing mothers should discuss risks with their healthcare provider.

To order Hytrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Hytrin (terazosin) shares the same class mechanism as drugs like doxazosin and prazosin, but differences exist in dosing frequency, half‑life, and side‑effect profile. Terazosin often requires once‑daily dosing and may have a slightly lower incidence of first‑dose orthostatic hypotension compared with some older agents.

Hytrin tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Hytrin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients are advised to follow the prescribing physician’s instructions regarding timing and whether to take the dose in the morning or evening.

The most serious risks include severe hypotension leading to fainting, priapism, and allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience sudden dizziness, prolonged erection, swelling of the face or throat, or any signs of an acute allergic response.

Hytrin is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation. It should be used with caution, or avoided, in individuals with severe liver disease, uncontrolled heart failure, or those who are already on multiple potent antihypertensive agents that could cause additive blood‑pressure lowering.